Philadelphia, where another 1,100 people died of an overdose in 2018, is slowly navigating toward opening a supervised injection site, a move that has prompted a debate among harm reduction advocates and law-and-order types about the best way to address the overdose crisis.
Safehouse, a nonprofit, has been incorporated with the sole purpose of opening a site. Quickly after incorporating, the U.S. attorney sued Safehouse, arguing that the site is illegal, in an attempt to prevent them from opening. The suit is currently in court, but Safehouse has made progress, recently announcing a location.
While Philadelphia’s alarming overdose rate adds urgency to this initiative, the city doesn’t need to reinvent the wheel. There are already about 120 supervised injection sites around the globe.
The Inquirer wanted to hear from people on the ground who made some of these sites a reality (or are trying to do so) with the hope that as Philadelphia moves forward, those involved can learn from the hard work of people who have already been through the process. Here are my takeaways from these discussions, followed by a deeper reflection from the people doing the work to launch and operate these sites.